Cannabis Stocks Rally as Sector Posts Strongest Weekly Gains in 2024
Cannabis equities surge on renewed investor optimism, with sector ETFs climbing as regulatory momentum and earnings expectations drive buying activity.
Cannabis stocks are delivering their strongest weekly performance of 2024, with major sector ETFs climbing double digits as investor sentiment shifts decidedly bullish. The AdvisorShares Pure US Cannabis ETF (MSOS) has gained over 12% this week, while the ETFMG Alternative Harvest ETF (MJ) posted similar gains, marking the most sustained buying pressure the sector has seen since early 2023.
The rally stems from converging catalysts that have reignited institutional interest in cannabis equities. Recent state-level legalization victories in key markets have expanded the total addressable market, while improved cash flow metrics from leading multistate operators suggest the industry's maturation phase is accelerating. Banking reform discussions in Congress have also provided a regulatory tailwind, with investors betting on eventual federal progress.
Multistate operators are leading the charge, with several names posting 20%+ weekly gains as traders position ahead of upcoming quarterly earnings. The sector's improved fundamentals - including positive EBITDA margins and declining cash burn rates - have created a more compelling investment thesis compared to the speculative fervor of 2021. Institutional money managers who previously avoided cannabis exposure are now conducting due diligence on sector leaders.
Options activity reflects the bullish momentum, with call volume spiking across cannabis names and implied volatility reaching three-month highs. The sector's correlation with broader risk assets has decreased, suggesting cannabis is attracting dedicated capital rather than riding general market sentiment. Technical indicators point to potential continuation, with several cannabis ETFs breaking through key resistance levels on heavy volume.
This week's performance represents a critical inflection point for cannabis equities, which have underperformed broader markets for two consecutive years. If the rally sustains through month-end, it could signal the beginning of a longer-term rerating as the industry transitions from growth-at-any-cost to sustainable profitability. The test will be whether companies can deliver operational improvements that justify current valuations when earnings season arrives.